Literature DB >> 16796705

Brain T1 intensity changes after levodopa administration in healthy subjects: a voxel-based morphometry study.

Pilar Salgado-Pineda1, Pauline Delaveau, Carles Falcon, Olivier Blin.   

Abstract

AIM: To test T1 intensity variations induced by levodopa administration in the regional fixation area in the human brain.
METHOD: Using non-invasive magnetic resonance imaging (MRI) technique [T1-weighted sequence MPRAGE; TE/TR/TI = 5/25/800 ms; impulsion angle = 15 degrees; field of view = 256 x 230 x 180 mm3; acquisition matrix = 256 x 192 x 104; reconstruction matrix = 256 x 256 x 128), we tested changes in the T1 MRI signal intensity resulting in changes in the grey matter automatic classification after administration of a single dose of 100 mg of levodopa by a voxel-based morphometry method (VBM) in 12 healthy subjects.
RESULTS: The VBM analysis demonstrated an increased number of voxels attributed to grey matter after levodopa administration in an anatomical cluster which included substantia nigra, tegmental ventral area and subthalamic nucleus bilaterally, the principal origin and first relay nuclei of projections in brain dopaminergic systems (t = 8.61; corrected for all grey matter volume P < 0.001).
CONCLUSION: Our results suggest that levodopa administration could induce an MRI T1 signal intensity variation that is not evident to the naked eye, but is detectable by measuring local signal intensities. Possible clinical applications are discussed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16796705      PMCID: PMC1885173          DOI: 10.1111/j.1365-2125.2006.02695.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  18 in total

1.  Cerebral asymmetry and the effects of sex and handedness on brain structure: a voxel-based morphometric analysis of 465 normal adult human brains.

Authors:  C D Good; I Johnsrude; J Ashburner; R N Henson; K J Friston; R S Frackowiak
Journal:  Neuroimage       Date:  2001-09       Impact factor: 6.556

Review 2.  Magnetic resonance imaging in drug discovery: lessons from disease areas.

Authors:  Nicolau Beckmann; Didier Laurent; Bruno Tigani; Rogério Panizzutti; Markus Rudin
Journal:  Drug Discov Today       Date:  2004-01-01       Impact factor: 7.851

Review 3.  Techniques: magnetic resonance imaging of the lung provides potential for non-invasive preclinical evaluation of drugs.

Authors:  Nicolau Beckmann; Bruno Tigani; Lazzaro Mazzoni; John R Fozard
Journal:  Trends Pharmacol Sci       Date:  2003-10       Impact factor: 14.819

Review 4.  Human pharmacological MRI.

Authors:  Garry Honey; Ed Bullmore
Journal:  Trends Pharmacol Sci       Date:  2004-07       Impact factor: 14.819

Review 5.  Parkinson's disease.

Authors:  Ali Samii; John G Nutt; Bruce R Ransom
Journal:  Lancet       Date:  2004-05-29       Impact factor: 79.321

6.  Brain magnetic resonance imaging with contrast dependent on blood oxygenation.

Authors:  S Ogawa; T M Lee; A R Kay; D W Tank
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

7.  [Pharmacokinetic comparison of Sinemet and Grifoparkin (levodopa/carbidopa 250/25 mg) in Parkinson s disease: a single dose study].

Authors:  Pedro Chaná; Angélica Fierro; Miguel Reyes-Parada; Patricio Sáez-Briones
Journal:  Rev Med Chil       Date:  2003-06       Impact factor: 0.553

8.  A voxel-based morphometric study of ageing in 465 normal adult human brains.

Authors:  C D Good; I S Johnsrude; J Ashburner; R N Henson; K J Friston; R S Frackowiak
Journal:  Neuroimage       Date:  2001-07       Impact factor: 6.556

9.  L-Dopa-induced sedation: a double-blind cross-over controlled study versus triazolam and placebo in healthy volunteers.

Authors:  N Andreu; J J Chalé; J M Senard; C Thalamas; J L Montastruc; O Rascol
Journal:  Clin Neuropharmacol       Date:  1999 Jan-Feb       Impact factor: 1.592

Review 10.  The role of iron in senescence of dopaminergic neurons in Parkinson's disease.

Authors:  M B Youdim; P Riederer
Journal:  J Neural Transm Suppl       Date:  1993
View more
  14 in total

1.  Prediction and reverse prediction in therapeutics and toxicology.

Authors:  J M Ritter
Journal:  Br J Clin Pharmacol       Date:  2008-10       Impact factor: 4.335

2.  Progression of brain atrophy in the early stages of Parkinson's disease: a longitudinal tensor-based morphometry study in de novo patients without cognitive impairment.

Authors:  Carlo Tessa; Claudio Lucetti; Marco Giannelli; Stefano Diciotti; Michele Poletti; Sabrina Danti; Filippo Baldacci; Claudio Vignali; Ubaldo Bonuccelli; Mario Mascalchi; Nicola Toschi
Journal:  Hum Brain Mapp       Date:  2014-01-22       Impact factor: 5.038

3.  Decomposing cerebral blood flow MRI into functional and structural components: a non-local approach based on prediction.

Authors:  Benjamin M Kandel; Danny J J Wang; John A Detre; James C Gee; Brian B Avants
Journal:  Neuroimage       Date:  2014-11-01       Impact factor: 6.556

4.  An investigation of regional cerebral blood flow and tissue structure changes after acute administration of antipsychotics in healthy male volunteers.

Authors:  Peter C T Hawkins; Tobias C Wood; Anthony C Vernon; Alessandro Bertolino; Fabio Sambataro; Juergen Dukart; Emilio Merlo-Pich; Celine Risterucci; Hanna Silber-Baumann; Eamonn Walsh; Ndabezinhle Mazibuko; Fernando O Zelaya; Mitul A Mehta
Journal:  Hum Brain Mapp       Date:  2017-10-23       Impact factor: 5.038

Review 5.  Maladaptive plasticity in levodopa-induced dyskinesias and tardive dyskinesias: old and new insights on the effects of dopamine receptor pharmacology.

Authors:  Antonio Cerasa; Alfonso Fasano; Francesca Morgante; Giacomo Koch; Aldo Quattrone
Journal:  Front Neurol       Date:  2014-04-09       Impact factor: 4.003

6.  Morphometric changes in the reward system of Parkinson's disease patients with impulse control disorders.

Authors:  Clelia Pellicano; Flavia Niccolini; Kit Wu; Sean S O'Sullivan; Andrew D Lawrence; Andrew J Lees; Paola Piccini; Marios Politis
Journal:  J Neurol       Date:  2015-09-26       Impact factor: 4.849

7.  Differential diagnosis tool for parkinsonian syndrome using multiple structural brain measures.

Authors:  Miho Ota; Yasuhiro Nakata; Kimiteru Ito; Kouhei Kamiya; Masafumi Ogawa; Miho Murata; Satoko Obu; Hiroshi Kunugi; Noriko Sato
Journal:  Comput Math Methods Med       Date:  2013-03-20       Impact factor: 2.238

8.  DTI and VBM reveal white matter changes without associated gray matter changes in patients with idiopathic restless legs syndrome.

Authors:  Marcus Belke; Johannes T Heverhagen; Boris Keil; Felix Rosenow; Wolfgang H Oertel; Karin Stiasny-Kolster; Susanne Knake; Katja Menzler
Journal:  Brain Behav       Date:  2015-07-30       Impact factor: 2.708

Review 9.  Brain morphometry and the neurobiology of levodopa-induced dyskinesias: current knowledge and future potential for translational pre-clinical neuroimaging studies.

Authors:  Clare J Finlay; Susan Duty; Anthony C Vernon
Journal:  Front Neurol       Date:  2014-06-12       Impact factor: 4.003

10.  The DARS (Dopamine Augmented Rehabilitation in Stroke) trial: protocol for a randomised controlled trial of Co-careldopa treatment in addition to routine NHS occupational and physical therapy after stroke.

Authors:  Bipin B Bhakta; Suzanne Hartley; Ivana Holloway; J Alastair Couzens; Gary A Ford; David Meads; Catherine M Sackley; Marion F Walker; Sharon P Ruddock; Amanda J Farrin
Journal:  Trials       Date:  2014-08-08       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.